Your browser doesn't support javascript.
loading
Longitudinal prevalence and determinants of pain in multiple sclerosis: results from the German National Multiple Sclerosis Cohort study.
Heitmann, Henrik; Haller, Bernhard; Tiemann, Laura; Mühlau, Mark; Berthele, Achim; Tölle, Thomas R; Salmen, Anke; Ambrosius, Björn; Bayas, Antonios; Asseyer, Susanna; Hartung, Hans-Peter; Heesen, Christoph; Stangel, Martin; Wildemann, Brigitte; Haars, Sarah; Groppa, Sergiu; Luessi, Felix; Kümpfel, Tania; Nischwitz, Sandra; Meuth, Sven G; Klotz, Luisa; Linker, Ralf A; Zettl, Uwe K; Ziemann, Ulf; Tumani, Hayrettin; Tackenberg, Björn; Zipp, Frauke; Wiendl, Heinz; Gold, Ralf; Hemmer, Bernhard; Ploner, Markus.
Afiliación
  • Heitmann H; Department of Neurology, Technical University of Munich (TUM), School of Medicine, Munich, Germany.
  • Haller B; TUM, School of Medicine, Institute of Medical Informatics, Statistics and Epidemiology, Munich, Germany.
  • Tiemann L; Department of Neurology, Technical University of Munich (TUM), School of Medicine, Munich, Germany.
  • Mühlau M; Department of Neurology, Technical University of Munich (TUM), School of Medicine, Munich, Germany.
  • Berthele A; Department of Neurology, Technical University of Munich (TUM), School of Medicine, Munich, Germany.
  • Tölle TR; Department of Neurology, Technical University of Munich (TUM), School of Medicine, Munich, Germany.
  • Salmen A; Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.
  • Ambrosius B; Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Bayas A; Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.
  • Asseyer S; Department of Neurology, University Hospital Augsburg, Augsburg, Germany.
  • Hartung HP; NeuroCure Clinical Research Center, Experimental and Clinical Research Center, Charité, University Medicine Berlin, Max Delbrueck, Center for Molecular Medicine, Berlin, Germany.
  • Heesen C; Department of Neurology, Heinrich-Heine University, Düsseldorf, Germany.
  • Stangel M; Institute for Neuroimmunology und Multiple Sclerosis, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.
  • Wildemann B; Clinical Neuroimmunology and Neurochemistry, Department of Neurology, Hannover Medical School, Hannover, Germany.
  • Haars S; Department of Neurology, University of Heidelberg, Heidelberg, Germany.
  • Groppa S; Department of Neurology, University of Leipzig, Leipzig, Germany.
  • Luessi F; Department of Neurology and Focus Program Translational Neuroscience (FTN), Rhine Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Kümpfel T; Department of Neurology and Focus Program Translational Neuroscience (FTN), Rhine Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Nischwitz S; Institute of Clinical Neuroimmunology, Ludwig Maximilian University of Munich, Munich, Germany.
  • Meuth SG; Neurology, Max-Planck-Institute of Psychiatry, Munich, Germany.
  • Klotz L; Department of Neurology, University Hospital Münster, Westfälische-Wilhelms-University Münster, Münster, Germany.
  • Linker RA; Department of Neurology, University Hospital Münster, Westfälische-Wilhelms-University Münster, Münster, Germany.
  • Zettl UK; Department of Neurology, University of Regensburg, Medbo Hospital for Neurology, Regensburg, Germany.
  • Ziemann U; Department of Neurology, University of Rostock, Rostock, Germany.
  • Tumani H; Department of Neurology and Stroke, Hertie Institute for Clinical Brain Research, Eberhard-Karls-University Tübingen, Tübingen, Germany.
  • Tackenberg B; Department of Neurology, University of Ulm, Ulm, Germany.
  • Zipp F; Clinic of Neurology Dietenbronn, Schwendi, Germany.
  • Wiendl H; Department of Neurology, Philipps-University Marburg, Marburg, Germany.
  • Gold R; Department of Neurology and Focus Program Translational Neuroscience (FTN), Rhine Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Hemmer B; Department of Neurology, University Hospital Münster, Westfälische-Wilhelms-University Münster, Münster, Germany.
  • Ploner M; Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.
Pain ; 161(4): 787-796, 2020 04.
Article en En | MEDLINE | ID: mdl-32197038
ABSTRACT
Pain is frequent in multiple sclerosis (MS) and includes different types, with neuropathic pain (NP) being most closely related to MS pathology. However, prevalence estimates vary largely, and causal relationships between pain and biopsychosocial factors in MS are largely unknown. Longitudinal studies might help to clarify the prevalence and determinants of pain in MS. To this end, we analyzed data from 410 patients with newly diagnosed clinically isolated syndrome or relapsing-remitting MS participating in the prospective multicenter German National MS Cohort Study (NationMS) at baseline and after 4 years. Pain was assessed by self-report using the PainDETECT Questionnaire. Neuropsychiatric assessment included tests for fatigue, depression, and cognition. In addition, sociodemographic and clinical data were obtained. Prevalence of pain of any type was 40% and 36% at baseline and after 4 years, respectively, whereas prevalence of NP was 2% and 5%. Pain of any type and NP were both strongly linked to fatigue, depression, and disability. This link was even stronger after 4 years than at baseline. Moreover, changes in pain, depression, and fatigue were highly correlated without any of these symptoms preceding the others. Taken together, pain of any type seems to be much more frequent than NP in early nonprogressive MS. Moreover, the close relationship between pain, fatigue, and depression in MS should be considered for treatment decisions and future research on a possible common pathophysiology.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Esclerosis Múltiple Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Pain Año: 2020 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Esclerosis Múltiple Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Pain Año: 2020 Tipo del documento: Article País de afiliación: Alemania